Seegene said this week that BioMérieux has licensed its DPO and TOCE technologies to develop multiplexed molecular tests for food safety.
Seegene's DPO (dual-priming oligonucleotide) and TOCE (tagging oligonucleotide capture and extension) technologies enable highly multiplexed assays based on real-time PCR.
DPO can be used to block extension of non-specifically primed templates, generating consistently high specificity; while TOCE enables simultaneous multiplexed assays by separating genes that have been amplified by real-time PCR technology based on differences in their melting temperatures, Seegene said.
"We believe that the adoption of our leading multiplexing technology will curtail future food contamination outbreaks, save lives, and help to grow this important market," Seegene CEO and CTO Jong-Yoon Chun said in a statement.
Financial terms of the agreement were not disclosed.
Seegene last year inked a similar licensing agreement for food safety testing with DuPont Nutrition & Health.